Tesamorelin vs Selank
A comprehensive, data-driven comparison of Tesamorelin (Egrifta) and Selank (TP-7). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Tesamorelin Egrifta, TH9507 | Selank TP-7 |
|---|---|---|
| FDA Status | FDA Approved | Not submitted |
| Category | Growth Hormone | Cognitive Enhancement |
| Primary Use | HIV-associated lipodystrophy | Anxiety disorders and cognitive enhancement |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $200 - $1,500/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Nasal spray |
| Typical Dose | 2mg daily | 2-3 drops per nostril 2-3x daily |
| Frequency | Daily | Daily |
| Mechanism | Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone production | Synthetic peptide analog of tuftsin that modulates GABA, serotonin, and norepinephrine for anxiolytic effects |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | High | Moderate |
| Clinical Trial Phase | Approved | N/A |
Key Differences
- 1Tesamorelin is FDA-approved, while Selank is currently not submitted.
- 2Selank is generally more affordable ($40 - $80/mo) compared to Tesamorelin ($200 - $1,500/mo).
- 3Tesamorelin is administered via subcutaneous injection, while Selank uses nasal spray.
- 4Tesamorelin has high-quality evidence, while Selank has moderate-quality evidence.
- 5They belong to different categories: Tesamorelin (Growth Hormone) vs Selank (Cognitive Enhancement).
Which Is Better For...
Tesamorelin
Those seeking an FDA-approved treatment with established safety data
Selank
More budget-friendly option with lower monthly costs
Selank
Fewer commonly reported side effects
Tesamorelin
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Tesamorelin | $200 - $1,500/mo | FDA Approved | Theratechnologies |
| Selank | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Tesamorelin works via Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone. Selank works via Synthetic peptide analog of tuftsin that modulates GABA, serotonin, and norepinephrine for. They differ in FDA approval status, efficacy data, and cost.
Tesamorelin typically costs $200 - $1,500/mo, while Selank costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Tesamorelin is FDA-approved. Selank is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Tesamorelin include Injection site reactions, Arthralgia, Peripheral edema. Common side effects of Selank include Nasal irritation, Mild drowsiness, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Tesamorelin is an FDA-approved synthetic growth hormone releasing hormone analog specifically indicated for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. A new weekly reco...
View Full Tesamorelin GuideSelank is a synthetic heptapeptide developed in Russia as an anxiolytic and nootropic agent. It has been shown to reduce anxiety without causing sedation or addiction, while potentially improving memo...
View Full Selank GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Tesamorelin and Selank should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.